文献速递头颈外科

恶性涎腺肿瘤治疗模式20年SEER数据库分析

Management of Malignant Salivary Gland Tumors: A 20-Year SEER Database Analysis.
PubMed 文献 · Otolaryngol Head Neck Surg · 2026-08-17

该研究基于SEER数据库回顾性分析2000至2021年24029例恶性涎腺肿瘤患者,按治疗方式和分期分类。手术为主流治疗,单纯手术占36.3%,手术联合辅助放疗占36.5%;单纯化疗虽显著增长但使用仍少。分期分析显示局限和区域肿瘤比例增加,远处转移下降。

要点

  • 手术仍是恶性涎腺肿瘤治疗的基石。
  • 手术联合辅助放疗是常见治疗模式之一。
  • 单纯化疗使用显著增加但总体仍不常用。

核心结论

  • 手术仍是恶性涎腺肿瘤管理的基石,但联合治疗模式的使用正在增加。

研究设计与样本

  • 回顾性队列研究,基于SEER数据库分析2000至2021年诊断的24029例恶性涎腺肿瘤病例。

主要发现

  • 单纯手术占36.3%,手术联合辅助放疗占36.5%,两者构成大多数治疗。
  • 单纯化疗随时间显著增加,年度百分比变化(APC)为+5.81%(95%CI 3.46-9.24,P<.05),但仍不常用。
  • 联合手术、化疗和放疗的模式在研究期间也显示适度增长。
  • 分期分析显示局限和区域肿瘤比例增加,远处病变下降。

临床怎么用

  • 临床应认识到手术的核心地位,同时关注联合治疗模式增长的趋势以指导多学科个体化诊疗。

局限性

  • 未来需整合临床结局和组织学亚型的研究来阐明扩展的系统性和联合治疗模式的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Malignant salivary gland tumors represent a heterogeneous group of neoplasms with variable management. This study evaluated trends in therapeutic approaches to these cancers to inform evidence-based, personalized care and optimize patient outcomes. STUDY DESIGN: Retrospective cohort study. SETTING: Population-based analysis using the Surveillance, Epidemiology, and End Results (SEER) database. METHODS: Cases of malignant salivary gland tumors diagnosed between 2000 and 2021 were categorized by treatment modality and stage at diagnosis. Trends over time were assessed using JoinPoint segmented log-linear regression. RESULTS: A total of 24,029 patients were included. Surgery alone (36.3%) and surgery with adjuvant radiation (36.5%) comprised the majority of treatments. Chemotherapy alone increased significantly over time (annual percent change [APC] +5.81%; 95% CI, 3.46-9.24; P < .05), though it remained infrequently used. Combined modalities including surgery, chemotherapy, and radiation also showed modest growth over the study period. Stage analysis revealed increasing proportions of localized and regional tumors and a decline in distant disease. CONCLUSION: Surgery remains the cornerstone of malignant salivary gland tumor management, but use of combined treatment approaches is rising, likely reflecting advances in systemic therapies and radiation techniques. Awareness of these trends is critical for guiding multidisciplinary, personalized care. Future studies integrating clinical outcomes and histologic subtype are warranted to clarify the role of expanding systemic and combined modalities.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Stewart C, Eyring JB, Felix B, et al. Management of Malignant Salivary Gland Tumors: A 20-Year SEER Database Analysis. Otolaryngol Head Neck Surg. 2026. PMID: 42606088. doi:10.1002/ohn.70375

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。